Baiyunshan's Penicillin Sodium Injection Achieves Generic Drug Equivalence

Stock News
02/11

Baiyunshan (00874) announced that its subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., recently received approval from the National Medical Products Administration for its supplemental drug application. The 0.96g (1.6 million units) injection of penicillin sodium has passed the consistency evaluation for generic drug quality and efficacy. Penicillin sodium injection is used to treat various infections caused by susceptible bacteria, such as abscesses, bacteremia, pneumonia, and endocarditis. Penicillin is the preferred treatment for infections including hemolytic streptococcus infections, pneumococcal infections, non-penicillinase-producing staphylococcal infections, anthrax, tetanus, gas gangrene and other clostridial infections, syphilis (including congenital syphilis), leptospirosis, relapsing fever, diphtheria, and when combined with aminoglycosides for treating streptococcus viridans endocarditis.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10